Better Therapeutics Inc logo

Better Therapeutics Inc Share Price (NASDAQ: BTTX)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 20 Sep 2024

Check the interactive Better Therapeutics Inc Stock chart to analyse performance

Better Therapeutics Inc Key Stats

Check Better Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.0E-4
Open
$2.0E-4
Market Capitalization
$5.5K
Today's Volume
$358.0
Revenue TTM
$0.0
EBITDA
$-29.2M
Earnings Per Share (EPS)
$-1.1
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1021.64%

Global Institutional Holdings in Better Therapeutics Inc

  • Name

    Holdings %

  • Capital Investment Advisory Services, LLC

    0.13%

  • XTX Topco Ltd

    0.06%

  • JANE STREET GROUP, LLC

    0.02%

Analyst Recommendation on Better Therapeutics Inc Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Better Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Better Therapeutics Inc

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
Organization
Better Therapeutics Inc
Employees
54
CEO
Mr. David P. Perry M.B.A.
Industry
Miscellaneous

Important FAQs about investing in BTTX Stock from India :

What is Better Therapeutics Inc share price today?

Better Therapeutics Inc share price today is as on at the close of the market. Better Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Better Therapeutics Inc share?

Better Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Better Therapeutics Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Better Therapeutics Inc Stock (BTTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Better Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Better Therapeutics Inc Shares .

What is the minimum amount required to buy Better Therapeutics Inc Stock (BTTX) from India?

Indian investors can start investing in Better Therapeutics Inc (BTTX) shares with as little as ₹87.7613 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹877.61 in Better Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Better Therapeutics Inc has given to Indian investors in the last 5 years?

Better Therapeutics Inc stock has given 0.0% share price returns and 19.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?